I would actually disagree with that. Given the rate of approval in Europe versus Canada, we're just below Europe from the reports. Looking at the analysis of the time it takes to approve patents and drugs in Europe versus Canada, I find it's generally about 10 days shorter in Canada than in Europe.
This number has been a bit compounded by a past report. The Norton Rose report had a number of issues. It compared approving generic drugs in Europe versus new formulas, new drugs, in Canada. It's really apples and oranges. However, when you look at the facts, the approval time in Canada is either on par or shorter.